MedPath
TGA Approval

DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial (428033)

428033

DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial

Reach Pharmaceuticals Pty Ltd

March 24, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/b60db7d90dc62d9cd371469ee8b1911e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/e3c76da7f91eb08a6480a2791ea88e6a.pdf

Active Ingredients

dexrazoxane

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXRAZOXANE-REACH dexrazoxane 250 mg powder for injection for infusion vial (428033) - TGA 批准文号 | MedPath